Sometimes what feels exciting in the moment can come with a cost you didn't see coming. What starts as harmless fun or a ...
RAPT Therapeutics, Inc. ( NASDAQ: RAPT) Discusses Top Line Phase II Results for RPT-904 in Chronic Spontaneous Urticaria October 20, 2025 8:30 AM EDT Good morning, and welcome to RAPT's conference ...
Bayer announced today the U.S. Food and Drug Administration (FDA) has approved Lynkuet® (elinzanetant) 60mg capsules, the first and only dual neurokinin (NK) targeted therapy,1 neurokinin 1 (NK1) and ...
Group sales In the first nine months of 2025, Roche achieved sales growth of 7% (2% in CHF) to CHF 45.9 billion due to strong demand for our pharmaceutical and diagnostic products.
Whether your loved ones are outdoorsy or homebodies, health-conscious or lovers of a little luxury, our vegan-friendly gift guide has something for everyone.
Covariate adjustment can offer several potential benefits in the analysis of cluster randomised trials. These benefits ...
A new study has revealed over 20,000 people in Britain could unknowingly be living with Parkinson's disease as diagnosis ...